SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for VERU INC. (VERU) (CIK 0000863894) (VERU) — Sep 3, 2015

VERU INC. (VERU) (CIK 0000863894)
Date: Sept. 3, 2015 · CIK: 0000863894 · Accession: 0000000000-15-044263

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
September 3, 2015
Author
/s/ John Cash
Form
UPLOAD
Company
VERU INC. (VERU) (CIK 0000863894)

Letter

September 3, 2015 Mail Stop 4631 Via E-mail Ms. Michele Greco, VP and Chief Financial Officer The Female Health Company 515 N. State Street, Suite 2225 Chicago, IL 60654

Re: The Female Health Company Form 10-K for the year ended September 30, 2014 Filed December 2, 2014 File No. 1 -13602

Dear Ms. Greco :

We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities la ws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ John Cash

Show Raw Text
September 3, 2015
Mail Stop 4631

Via E-mail
Ms. Michele Greco, VP and Chief Financial Officer
The Female Health Company
515 N. State Street, Suite 2225
Chicago, IL  60654

Re: The Female Health Company
 Form 10-K for the year ended September 30, 2014
Filed December 2, 2014
File No. 1 -13602

Dear Ms. Greco :

We have completed our review of your filing .  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filing and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities la ws of the United States.  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

/s/ John Cash

John Cash
Branch Chief
Office of Manufacturing and
Construction